Genetics of Type 2 diabetes

Diabetic Medicine

Volumn 22, Issue 5, 2005, Pages 517-535

  Barroso, Inês ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Genetics; Insulin resistance; MODY; Type 2 diabetes

Indexed keywords

COPING BEHAVIOR; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC LINKAGE; GENOTYPE; HUMAN; INSULIN RESISTANCE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; REPRODUCIBILITY; RESOURCE ALLOCATION; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADULT; CHILD; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN RESISTANCE; LINKAGE (GENETICS);

EID: 17844373857     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01550.x     Document Type: Review

References (257)

1. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 1993; 16: 157-177.
2. Serjeantson SW, Owerbach D, Zimmet P, Nerup J, Thoma K. Genetics of diabetes in Nauru: effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism. Diabetologia 1983; 25: 13-17.
3. Knowler WC, Williams RC, Pettitt DJ, Steinberg AG. Gm3;5,13,14 and type 2 diabetes mellitus: an association in American Indians with genetic admixture. Am J Hum Genet 1988; 43: 520-526.
4. Simmons D, Williams DR, Powell MJ. The Coventry Diabetes Study: prevalence of diabetes and impaired glucose tolerance in Europids and Asians. Q J Med 1991; 81: 1021-1030.
5. Chaturvedi N, McKeigue PM, Marmot MG. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension 1993; 22: 90-96.
6. Mather HM, Keen H. The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J (Clin Res Ed) 1985; 291: 1081-1084.
7. Greenhalgh PM. Diabetes in British south Asians: nature, nurture, and culture Diabet Med 1997; 14: 10-18.
8. Groop LC, Tuomi T. Non-insulin-dependent diabetes mellitus-a collision between thrifty genes and an affluent society. Ann Med 1997; 29: 37-53.
9. Meigs J, Cupples L, Wilson P. Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 2000; 49: 2201-2207.
10. Kobberling J. Studies on the genetic heterogeneity of diabetes mellitus. Diabetologia 1971; 7: 46-49.
11. Simpson NE. Multifactorial inheritance: a possible hypothesis for diabetes. Diabetes 1964; 13: 462-471.
12. Thomas F, Balkau B, Vauzelle-Kervroedan F, Papoz L. Maternal effect and familial aggregation in NIDDM. The CODIAB Study. CODIAB-INSERM-ZENECA Study Group Diabetes 1994; 43: 63-67.
13. Knowler WC, Pettitt DJ, Lillioja Sea. Genetic and environmental factors in the development of diabetes mellitus in Pima Indians. In: Smith, U Eriksson, S Lindgarde, F, eds. Genetic Susceptibility to Environmental Factors-a Challenge for Public Intervention. Stockholm: Almqvist and Wiksell International 1998: 67-76.
14. Viswanathan M, Mohan V, Snehalatha C, Ramachandran A. High prevalence of type 2 (non-insulin-dependent) diabetes among the offspring of conjugal type 2 diabetic parents in India. Diabetologia 1985; 28: 907-910.
15. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.
16. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987; 30: 763-768.
17. Committee DT. Diabetes mellitus in twins: a cooperative study in Japan. Committee on Diabetic Twins, Japan Diabetes Society. Diabetes Res Clin Pract 1988; 5: 271-280.
18. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin- dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992; 35: 1060-1067.
19. Matsuda A, Kuzuya T. Diabetic twins in Japan. Diabetes Res Clin Pract 1994; 24: S63-67.
20. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 1999; 42: 139-145.
21. Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD. Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 1999; 42: 146-150.
22. Hanson RL, Knowler WC. Type 2 diabetes mellitus and maturity-onset diabetes of the young. In: Bishop, T Sham, P, eds. Analysis of Multifactorial Disease. Oxford: BIOS Scientific Publishers 2000: 131-147.
23. Hales CN, Desai M, Ozanne SE. The Thrifty Phenotype hypothesis: how does it look after 5 years? Diabet Med 1997; 14: 189-195.
24. Ghosh S, Schork NJ. Genetic analysis of NIDDM. The study of quantitative traits. Diabetes 1996; 45: 1-14.
25. Fajans SS, Conn JW. Prediabetes, subclinical diabetes and latent clinical diabetes, interpretation, diagnosis and treatment. In: Leibel, DS Wrenshall, GS, eds. On the Nature and Treatment of Diabetes. Amsterdam: Excerpta Medica 1965: 641-656.
26. Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med 1974; 43: 339-357.
27. Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 1975; 24: 44-53.
28. Ledermann HM. Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? Diabetologia 1995; 38: 1482.
29. Bell GI, Xiang KS, Newman MV, Wu SH, Wright LG, Fajans SS et al. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 1991; 88: 1484-1488.
30. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 162-164.
31. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P et al. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet 1995; 9: 418-423.
32. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 1992; 356: 721-722.
33. Njolstad PR, Sovik O, Cuesta-Munoz A, Bjorkhaug L, Massa O, Barbetti F et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001; 344: 1588-1592.
34. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 1996; 384: 455-458.
35. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384: 458-460.
36. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994; 371:606-609.
37. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997; 17: 138-139.
38. Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K et al. β-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001; 50: S94-100.
39. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN et al. Mutation in hepatocyte nuclear factor-1β gene (TCF2) associated with MODY. Nat Genet 1997; 17: 384-385.
40. Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med 2002; 34: 207-216.
41. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999; 23: 323-328.
42. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971-980.
43. Velho G, Robert JJ. Maturity-onset diabetes of the young (MODY): genetic and clinical characteristics. Horm Res 2002; 57: 29-33.
44. Shimomura H, Sanke T, Hanabusa T, Tsunoda K, Furuta H, Nanjo K. Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes 2000; 49: 1597-1600.
45. Huopio H, Otonkoski T, Vauhkonen I, Reimann F, Ashcroft FM, Laakso M. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Lancet 2003; 361: 301-307.
46. Glaser B. Dominant SUR1 mutation causing autosomal dominant type 2 diabetes. Lancet 2003; 361: 272-273.
47. Longo N, Wang Y, Smith SA, Langley SD, DiMeglio LA, Giannella-Neto D. Genotype-phenotype correlation in inherited severe insulin resistance. Hum Mol Genet 2002; 11: 1465-1475.
48. Pickup J, Williams G. Textbook of Diabetes, 2nd edn. Oxford: Blackwell Science Ltd 1997.
49. Garg A, Wilson R, Barnes R, Arioglu E, Zaidi Z, Gurakan F et al. A gene for congenital generalized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab 1999; 84: 3390-3394.
50. Magre J, Delepine M, Khallouf E, Gedde-Dahl T Jr, Van Maldergem L, Sobel E et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 2001; 28: 365-370.
51. Windpassinger C, Auer-Grumbach M, Irobi J, Patel H, Petek E, Horl G et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 2004; 36: 271-276.
52. Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM et al. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 2002; 31: 21-23.
53. Van Maldergem L, Magre J, Khallouf TE, Gedde-Dahl T Jr, Delepine M, Trygstad O et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet 2002; 39: 722-733.
54. Rajab A, Heathcote K, Joshi S, Jeffery S, Patton M. Heterogeneity for congenital generalized lipodystrophy in seventeen patients from Oman. Am J Med Genet 2002; 110: 219-225.
55. Shackleton S, Lloyd DJ, Jackson SN, Evans R, Niermeijer MF, Singh BM et al. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet 2000; 24: 153-156.
56. Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000; 9: 109-112.
57. Mounkes L, Kozlov S, Burke B, Stewart CL. The laminopathies: nuclear structure meets disease. Curr Opin Genet Dev 2003; 13: 223-230.
58. Charniot JC, Pascal C, Bouchier C, Sebillon P, Salama J, Duboscq-Bidot L et al. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype. Hum Mutat 2003; 21: 473-481.
59. Caux F, Dubosclard E, Lascols O, Buendia B, Chazouilleres O, Cohen A et al. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 2003; 88: 1006-1013.
60. Sebillon P, Bouchier C, Bidot LD, Bonne G, Ahamed K, Charron P et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 2003; 40: 560-567.
61. Chen L, Lee L, Kudlow BA, Dos Santos HG, Sletvold O, Shafeghati Y et al. LMNA mutations in atypical Werner's syndrome. Lancet 2003; 362: 440-445.
62. Lloyd DJ, Trembath RC, Shackleton S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. Hum Mol Genet 2002; 11: 769-777.
63. Novelli G, Muchir A, Sangiuolo F, Helbling-Leclerc A, D'Apice MR, Massart C et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet 2002; 71: 426-431.
64. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA et al. Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999; 402: 880-883.
65. Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M et al. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-γ. Diabetes 2003; 52: 910-917.
66. Agarwal AK, Garg A. A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy. J Clin Endocrinol Metab 2002; 87: 408-411.
67. Hegele RA, Cao H, Frankowski C, Mathews ST, Leff T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 2002; 51: 3586-3590.
68. Savage DB, Agostini M, Barroso I, Gurnell M, Luan J, Meirhaeghe A et al. Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet 2002; 31: 379-384.
69. George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004; 304: 1325-1358.
70. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 2001; 292: 1728-1731.
71. Flier JS, Moller DE, Moses AC, O'Rahilly S, Chaiken RL, Grigorescu F et al. Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab 1993; 76: 1533-1541.
72. Collin GB, Marshall JD, Cardon LR, Nishina PM. Homozygosity mapping at Alstrom syndrome to chromosome 2p. Hum Mol Genet 1997; 6: 213-219.
73. Macari F, Lautier C, Girardet A, Dadoun F, Darmon P, Dutour A et al. Refinement of genetic localization of the Alstrom syndrome on chromosome 2p12-13 by linkage analysis in a North African family. Hum Genet 1998; 103: 658-661.
74. Collin GB, Marshall JD, Boerkoel CF, Levin AV, Weksberg R, Greenberg J et al. Alstrom syndrome: further evidence for linkage to human chromosome 2p13. Hum Genet 1999; 105: 474-479.
75. Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet 2002; 31: 74-78.
76. Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nat Genet 2002; 31: 79-83.
77. Yu CE, Oshima J, Fu YH, Wijsman EM, Hisama F, Alisch R et al. Positional cloning of the Werner's syndrome gene. Science 1996; 272: 258-262.
78. Gharani N, Waterworth DM, Batty S, White D, Gilling-Smith C, Conway GS et al. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997; 6: 397-402.
79. Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Pathogenesis of polycystic ovary syndrome. What is the role of obesity? Metabolism 2004; 53: 358-376.
80. Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, Polak MA, Koontz DA et al. Maternally transmitted diabetes and deafness associated with a 10.4-kb mitochondrial DNA deletion. Nat Genet 1992; 1: 11-15.
81. Goto Y, Nonaka I, Horai S. A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-653.
82. Kobayashi Y, Momoi MY, Tominaga K, Momoi T, Nihei K, Yanagisawa M et al. A point mutation in the mitochondrial tRNA (Leu) (UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 1990; 173: 816-822.
83. van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA et al. Mutation in mitochondrial tRNA (Leu) (UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992; 1: 368-371.
84. Maassen JA, van Essen E, van den Ouweland JM, Lemkes HH. Molecular and clinical aspects of mitochondrial diabetes mellitus. Exp Clin Endocrinol Diabetes 2001; 109: 127-134.
85. Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome) Nat Genet 1998; 20: 143-148.
86. Rotig A, Cormier V, Chatelain P, Francois R, Saudubray JM, Rustin P et al. Deletion of mitochondrial DNA in a case of early-onset diabetes mellitus, optic atrophy, and deafness (Wolfram syndrome, MIM 222300). J Clin Invest 1993; 91: 1095-1098.
87. Vieland VJ. The replication requirement. Nat Genet 2001; 29: 244-245.
88. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001; 29: 306-309.
89. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
90. Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M et al. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 1993; 42: 514-519.
91. Mitchell BD, Kammerer CM, O'Connell P, Harrison CR, Manire M, Shipman P et al. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes 1995; 44: 1046-1053.
92. Elbein SC, Chiu KC, Hoffman MD, Mayorga RA, Bragg KL, Leppert MF. Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes 1995; 44: 1259-1265.
93. Lesage S, Hani EH, Philippi A, Vaxillaire M, Hager J, Passa P et al. Linkage analyses of the MODY3 locus on chromosome 12q with late-onset NIDDM. Diabetes 1995; 44: 1243-1247.
94. Stern MP, Mitchell BD, Blangero J, Reinhart L, Krammerer CM, Harrison CR et al. Evidence for a major gene for type 11 diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes 1996; 45: 563-568.
95. Morton NE, Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci USA 1998; 95: 11389-11393.
96. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163-175.
97. Hanis CL, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13: 161-166.
98. Baier LJ, Permana PA, Yang X, Pratley RE, Hanson RL, Shen GQ et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000; 106: R69-73.
99. Hegele RA, Harris SB, Zinman B, Hanley AJ, Cao H. Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree. Diabetes Care 2001; 24: 1498-1499.
100. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 2001; 69: 544-552.
101. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolujewicz M, McGarvey ST et al. Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet 2001; 69: 1236-1244.
102. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H et al. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract 2002; 56: 147-152.
103. Elbein SC, Chu W, Ren Q, Hemphill C, Schay J, Cox NJ et al. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J Clin Endocrinol Metab 2002; 87: 650-654.
104. Garant MJ, Kao WH, Brancati F, Coresh J, Rami TM, Hanis CL et al. SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 2002; 51: 231-237.
105. Cox NJ. Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the calpain-10 gene. Hum Mol Genet 2001; 10: 2301-2305.
106. Weedon MN, Schwarz PE, Horikawa Y, Iwasaki N, Illig T, Holle R et al. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet 2003; 73: 1208-1212.
107. Song Y, Niu T, Manson JE, Kwiatkowski DJ, Liu S. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 2004; 74: 208-222.
108. Florez JC, Hirschhorn J, Altshuler D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genomics Hum Genet 2003; 4: 257-291.
109. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D et al. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 1998; 63: 1130-1138.
110. Elbein SC, Hoffman MD, Teng K, Leppert MF, Hasstedt SJ. A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes 1999; 48: 1175-1182.
111. Vionnet N, Hani El H, Dupont S, Gallina S, Francke S, Dotte S et al. Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome Iq21-q24. Am J Hum Genet 2000; 67: 1470-1480.
112. Wiltshire S, Hattersley AT, Hitman GA, Walker M, Levy JC, Sampson M et al. A genomewide scan for loci predisposing to type 2 diabetes in a UK population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 2001; 69: 553-569.
113. Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA. A genome-wide scan for loci linked to plasma levels of glucose and HbA (1c) in a community-based sample of Caucasian pedigrees. The Framingham Offspring Study. Diabetes 2002; 51: 833-840.
114. Hsueh WC, St Jean PL, Mitchell BD, Pollin TI, Knowler WC, Ehm MG et al. Genome-wide and fine-mapping linkage studies of type 2 diabetes and glucose traits in the Old Order Amish: evidence for a new diabetes locus on chromosome 14q11 and confirmation of a locus on chromosome 1q21-q24. Diabetes 2003; 52: 550-557.
115. Xiang K, Wang Y, Zheng T, Jia W, Li J, Chen L et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 2004; 53: 228-234.
116. Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, Brayer J et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 1996; 14: 90-94.
117. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB et al. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 1997; 46: 882-886.
118. Shaw JT, Lovelock PK, Kesting JB, Cardinal J, Duffy D, Wainwright B et al. Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. Diabetes 1998; 47: 1793-1796.
119. Ehm MG, Karnoub MC, Sakul H, Gottschalk K, Holt DC, Weber JL et al. Genomewide search for type 2 diabetes susceptibility genes in four American populations. Am J Hum Genet 2000; 66: 1871-1881.
120. Lindgren CM, Mahtani MM, Widen E, McCarthy MI, Daly MJ, Kirby A et al. Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet 2002; 70: 509-516.
121. Wiltshire S, Frayling TM, Groves CJ, Levy JC, Hitman GA, Sampson M et al. Evidence from a large UK family collection that genes influencing age of onset of type 2 diabetes map to chromosome 12p and to the MODY3/NIDDM2 locus on 12q24. Diabetes 2004; 53: 855-860.
122. Rotimi CN, Chen G, Adeyemo AA, Furbert-Harris P, Guass D, Zhou J et al. A genome-wide search for type 2 diabetes susceptibility genes in West Africans: the Africa America Diabetes Mellitus (AADM) Study. Diabetes 2004; 53: 838-841.
123. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 1997; 46: 876-881.
124. Zouali H, Hani EH, Philippi A, Vionnet N, Beckmann JS, Demenais F et al. A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum Mol Genet 1997; 6: 1401-1408.
125. Ghosh S, Watanabe RM, Hauser ER, Valle T, Magnuson VL, Erdos MR et al. Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci USA 1999; 96: 2198-2203.
126. Klupa T, Malecki MT, Pezzolesi M, Ji L, Curtis S, Langefeld CD et al. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13. 1-Q13 2 Diabetes 2000; 49: 2212-2216.
127. Permutt MA, Wasson JC, Suarez BK, Lin J, Thomas J, Meyer J et al. A genome scan for type 2 diabetes susceptibility loci in a genetically isolated population. Diabetes 2001; 50: 681-685.
128. Mori Y, Otabe S, Dina C, Yasuda K, Populaire C, Lecoeur C et al. Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p. Diabetes 2002; 51: 1247-1255.
129. Cox NJ, Frigge M, Nicolae DL, Concannon P, Hanis CL, Bell GI et al. Loci on chromosomes 2 (NIDDM 1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 1999; 21:213-215.
130. Ghosh S, Watanabe RM, Valle TT, Hauser ER, Magnuson VL, Langefeld CD et al. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 2000; 67: 1174-1185.
131. Demenais F, Kanninen T, Lindgren CM, Wiltshire S, Gaget S, Dandrieux C et al. A meta-analysis of four European genome screens (GIFT Consortium) shows evidence for a novel region on chromosome 17p11.2-q22 linked to type 2 diabetes. Hum Mol Genet 2003; 12: 1865-1873.
132. Goring HH, Terwilliger JD, Blangero J. Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet 2001; 69: 1357-1369.
133. Ioannidis JP. Genetic associations: false or true? Trends Mol Med 2003; 9: 135-138.
134. Ioannidis JP, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003; 361: 567-571.
135. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 177-182.
136. Stern MP, Duggirala R, Mitchell BD, Reinhart LJ, Shivakumar S, Shipman PA et al. Evidence for linkage of regions on chromosomes 6 and 11 to plasma glucose concentrations in Mexican Americans. Genome Res 1996; 6: 724-734.
137. Watanabe RM, Ghosh S, Langefeld CD, Valle TT, Hauser ER, Magnuson VL et al. The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet 2000; 67: 1186-1200.
138. Pratley RE, Thompson DB, Prochazka M, Baier L, Mon D, Ravussin E et al. An autosomal genomic scan for loci linked to prediabetic phenotypes in Pima Indians. J Clin Invest 1998; 101: 1757-1764.
139. Elbein SC, Hasstedt SJ. Genome-wide scan for prediabetic traits in Caucasian familial type 2 diabetes kindrids. Diabetes 2000; 49: A200.
140. Tiret L, Poirier O, Nicaud V, Barbaux S, Herrmann SM, Perret C et al. Heterogeneity of linkage disequilibrium in human genes has implications for association studies of common diseases. Hum Mol Genet 2002; 11: 419-429.
141. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
142. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES. High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229-232.
143. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ et al. Linkage disequilibrium in the human genome. Nature 2001; 411: 199-204.
144. Terwilliger JD, Haghighi F, Hiekkalinna TS, Goring HH. A biased assessment of the use of SNPs in human complex traits. Curr Opin Genet Dev 2002; 12: 726-734.
145. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
146. Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G et al. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of Type II diabetes mellitus in Caucasians. Diabetologia 1998; 41: 1511-1515.
147. Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med 2001; 18: 206-212.
148. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G et al. Large-ccale association studies of variants in genes encoding the pancreatic beta-cell K (ATP) channel subunits Kir6. 2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with Type 2 diabetes. Diabetes 2003; 52: 568-572.
149. Nielsen EM, Hansen L, Carstensen B, Echwald SM, Drivsholm T, Glumer C et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of Type 2 diabetes. Diabetes 2003; 52: 573-577.
150. Love-Gregory L, Wasson J, Lin J, Skolnick G, Suarez B, Permutt MA. An E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of Type II diabetes in Caucasians as the PPAR Pro12Ala variant. Diabetologia 2003; 46: 136-137.
151. Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. Plos Biol 2003; 1: 41.
152. Zhu Q, Yamagata K, Miura A, Shihara N, Horikawa Y, Takeda J et al. T130I mutation in HNF-4α gene is a loss-of-function mutation in hepatocytes and is associated with late-onset Type 2 diabetes mellitus in Japanese subjects. Diabetologia 2003; 46: 567-573.
153. Love-Gregory LD, Wasson J, Ma J, Jin CH, Glaser B, Suarez BK et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 gene on chromosome 20q is associated with Type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 2004; 53: 1134-1140.
154. Silander K, Mohlke KL, Scott LJ, Peck EC, Hollstein P, Skol AD et al. Genetic variation near the hepatocyte nuclear factor-4(α) gene predicts susceptibility to Type 2 diabetes. Diabetes 2004; 53: 1141-1149.
155. Jellema A, Zeegers MP, Feskens EJ, Dagnelie PC, Mensink RP. Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies. Diabetologia 2003; 46: 990-995.
156. Hansen T, Ambye L, Grarup N, Hansen L, Echwald SM, Ferrer J et al. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus. Diabetologia 2001; 44: 1330-1334.
157. Huxtable SJ, Saker PJ, Haddad L, Walker M, Frayling TM, Levy JC et al. Analysis of parent-offspring trios provides evidence for linkage and association between the insulin gene and type 2 diabetes mediated exclusively through paternally transmitted class III variable number tandem repeat alleles. Diabetes 2000; 49: 126-130.
158. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004; 350: 1838-1849.
159. Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004; 303: 1378-1381.
160. Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B. Hepatocyte nuclear factor-1α G319S. A private mutation in Oji-Cree associated with type 2 diabetes. Diabetes Care 1999; 22: 524.
161. Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham NJ. Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum Mol Genet 2002; 11: 1581-1583.
162. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003; 362: 1275-1281.
163. Krook A, Brueton L, O'Rahilly S. Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet 1993; 342: 277-278.
164. Accili D, Frapier C, Mosthaf L, McKeon C, Elbein SC, Permutt MA et al. A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes. EMBO J 1989; 8: 2509-2517.
165. Moller DE, Flier JS. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance). N Engl J Med 1988; 319: 1526-1529.
166. Inoue H, Ferrer J, Welling CM, Elbein SC, Hoffman M, Mayorga R et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes 1996; 45: 825-831.
167. Hansen T, Echwald SM, Hansen L, Moller AM, Almind K, Clausen JO et al. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 1998; 47: 598-605.
168. Hart LM, de Knijff P, Dekker JM, Stolk RP, Nijpels G, van der Does FE et al. Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with Type 11 diabetes mellitus in Dutch Caucasians. Diabetologia 1999; 42: 617-620.
169. Rissanen J, Markkanen A, Karkkainen P, Pihlajamaki J, Kekalainen P, Mykkanen L et al. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 2000; 23: 70-73.
170. Reis AF, Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Hum Genet 2000; 107: 138-144.
171. Meirhaeghe A, Helbecque N, Cottel D, Arveiler D, Ruidavets JB, Haas B et al. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study. Am J Med Genet 2001; 101: 4-8.
172. Ohta Y, Tanizawa Y, Inoue H, Hosaka T, Ueda K, Matsutani A et al. Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM. Diabetes 1998; 47: 476-481.
173. Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y et al. Association of Trp64Arg mutation of the β3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 1996; 39: 349-352.
174. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-351.
175. Ueda K, Tanizawa Y, Oota Y, Inoue H, Kizuki N, Tsukuda K et al. Prevalence of the Trp64Arg missense mutation of the β3-adrenergic receptor gene in Japanese subjects. Metabolism 1997; 46: 199-202.
176. Ghosh S, Langefeld CD, Ally D, Watanabe RM, Hauser ER, Magnuson VL et al. The W64R variant of the β3-adrenergic receptor is not associated with type II diabetes or obesity in a large Finnish sample. Diabetologia 1999; 42: 238-244.
177. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999; 42: 98-101.
178. Hara K, Boutin P, Mon Y, Tobe K, Dina C, Yasuda K et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536-540.
179. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 2002; 11: 2607-2614.
180. Shima Y, Nakanishi K, Odawara M, Kobayashi T, Ohta H. Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin Chim Acta 2003; 336: 89-96.
181. Elbein SC. Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology 2002; 143: 2012-2018.
182. Rasmussen SK, Urhammer SA, Pizzuti A, Echwald SM, Ekstrom CT, Hansen L et al. The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes 2000; 49: 1608-1611.
183. Gu HF, Almgren P, Lindholm E, Frittitta E, Pizzuti A, Trischitta V et al. Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes 2000; 49: 1601-1603.
184. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 1995; 95: 1281-1287.
185. Boullu-Sanchis S, Lepretre F, Hedelin G, Donnet JP, Schaffer P, Froguel P et al. Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. Diabetes Metab 1999; 25: 150-156.
186. Lei HH, Coresh J, Shuldiner AR, Boerwinkle E, Brancati FL. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyper-insulinemia in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 1999; 48: 1868-1872.
187. Hirai M, Suzuki S, Hinokio Y, Chiba M, Kasuga S, Hirai A et al. Group specific component protein genotype is associated with NIDDM in Japan. Diabetologia 1998; 41: 742-743.
188. Hirai M, Suzuki S, Hinokio Y, Hirai A, Chiba M, Akai H et al. Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance. J Clin Endocrinol Metab 2000; 85: 1951-1953.
189. Iyengar S, Hamman RF, Marshall JA, Majumder PP, Ferrell RE. On the role of vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study. Genet Epidemiol 1989; 6: 691-698.
190. Klupa T, Malecki M, Hanna L, Sieradzka J, Frey J, Warram JH et al. Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin. Eur J Endocrinol 1999; 141: 490-493.
191. Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Variations in the vitamin D-binding protein (Gc locus) and risk of Type 2 diabetes mellitus in French Caucasians. Metabolism 2001; 50: 366-369.
192. Hager J, Hansen L, Vaisse C, Vionnet N, Philippi A, Poller W et al. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet 1995; 9: 299-304.
193. Gough SC, Saker PJ, Pritchard LE, Merriman TR, Merriman ME, Rowe BR et al. Mutation of the glucagon receptor gene and diabetes mellitus in the UK: association or founder effect? Hum Mol Genet 1995; 4: 1609-1612.
194. Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y et al. A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus. Diabetologia 1995; 38: 983-985.
195. Huang X, Orho M, Lehto M, Groop L. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland. Diabetologia 1995; 38: 1246-1248.
196. Babadjanova G, Reincke M, Mora P, Chuchalin A, Allolio B. Polymorphism of the glucagon receptor gene and non-insulin-dependent diabetes mellitus in the Russian population. Exp Clin Endocrinol Diabetes 1997; 105: 225-226.
197. Tonolo G, Melis MG, Ciccarese M, Secchi G, Atzeni MM, Maioli M et al. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population. The Sardinian Diabetes Genetic Study Group. Diabetologia 1997; 40: 89-94.
198. Groop LC, Kankuri M, Schalin-Jantti C, Ekstrand A, Nikula-Ijas P, Widen E et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 10-14.
199. Zouali H, Velho G, Froguel P. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 1568.
200. Kuroyama H, Sanke T, Ohagi S, Furuta M, Furuta H, Nanjo K. Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia 1994; 37: 536-539.
201. Majer M, Mott DM, Mochizuki H, Rowles JC, Pedersen O, Knowler WC et al. Association of the glycogen synthase locus on 19ql3 with NIDDM in Pima Indians. Diabetologia 1996; 39: 314-321.
202. Shimomura H, Sanke T, Ueda K, Hanabusa T, Sakagashira S, Nanjo K. A missense mutation of the muscle glycogen synthase gene (M416V) is associated with insulin resistance in the Japanese population. Diabetologia 1997; 40: 947-952.
203. Shimokawa K, Kadowaki H, Sakura H, Otabe S, Hagura R, Kosaka K et al. Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 1994; 202: 463-469.
204. Rissanen J, Pihlajamaki J, Heikkinen S, Kekalainen P, Mykkanen L, Kuusisto J et al. New variants in the glycogen synthase gene (Gln71His, Met416Val) in patients with NIDDM from eastern Finland. Diabetologia 1997; 40: 1313-1319.
205. Moller AM, Urhammer SA, Dalgaard LT, Reneland R, Berglund L, Hansen T et al. Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4α in Caucasians with maturity onset NIDDM. Diabetologia 1997; 40: 980-983.
206. Malecki MT, Antonellis A, Casey P, Ji L, Wantman M, Warram JH et al. Exclusion of the hepatocyte nuclear factor 4α as a candidate gene for late-onset NIDDM linked with chromosome 20q. Diabetes 1998; 47: 970-972.
207. Price JA, Fossey SC, Sale MM, Brewer CS, Freedman BI, Wuerth JP et al. Analysis of the HNF4α gene in Caucasian type II diabetic nephropathic patients. Diabetologia 2000; 43: 364-372.
208. Sakagashira S, Sanke T, Hanabusa T, Shimomura H, Ohagi S, Kumagaye KY et al. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 1996; 45: 1279-1281.
209. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001; 50: 637-642.
210. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL et al. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in UK populations. Diabetes 2002; 51: 2313-2316.
211. Hart LM, Stolk RP, Heine RJ, Grobbee DE, van der Does FE, Maassen JA. Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: a population-based study. Am J Hum Genet 1996; 59: 1119-1125.
212. Hart LM, Stolk RP, Dekker JM, Nijpels G, Grobbee DE, Heine RJ et al. Prevalence of variants in candidate genes for type 2 diabetes mellitus in The Netherlands: the Rotterdam study and the Hoorn study. J Clin Endocrinol Metab 1999; 84: 1002-1006.
213. O'Rahilly S, Choi WH, Patel P, Turner RC, Flier JS, Moller DE. Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes 1991; 40: 777-782.
214. O'Rahilly S, Krook A, Morgan R, Rees A, Flier JS, Moller DE. Insulin receptor and insulin-responsive glucose transporter (GLUT 4) mutations and polymorphisms in a Welsh type 2 (non-insulin-dependent) diabetic population. Diabetologia 1992; 35: 486-489.
215. Hansen L, Hansen T, Clausen JO, Echwald SM, Urhammer SA, Rasmussen SK et al. The Val985Met insulin-receptor variant in the Danish Caucasian population: lack of associations with non-insulin-dependent diabetes mellitus or insulin resistance. Am J Hum Genet 1997; 60: 1532-1535.
216. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin- dependent diabetes mellitus. Lancet 1993; 342: 828-832.
217. Sigal RJ, Doria A, Warram JH, Krolewski AS. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 1657-1659.
218. Mammarella S, Romano F, Di Valerio A, Creati B, Esposito DL, Palmirotta R et al. Interaction between the G1057D variant of IRS-2 and overweight in the pathogenesis of type 2 diabetes. Hum Mol Genet 2000; 9: 2517-2521.
219. Stefan N, Kovacs P, Stumvoll M, Hanson RL, Lehn-Stefan A, Permana PA et al. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes 2003; 52: 1544-1550.
220. Wang H, Rissanen J, Miettinen R, Karkkainen P, Kekalainen P, Kuusisto J et al. New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes. Diabetes 2001; 50: 1949-1951.
221. D'Alfonso R, Marini MA, Frittitta L, Sorge R, Frontoni S, Porzio O et al. Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes. J Clin Endocrinol Metab 2003; 88: 317-322.
222. Schwanstecher C, Schwanstecher M. Nucleotide sensitivity of pancreatic ATP-sensitive potassium channels and type 2 diabetes. Diabetes 2002; 51: S358-362.
223. Sakura H, Wat N, Horton V, Millns H, Turner RC, Ashcroft FM. Sequence variations in the human Kir6.2 gene, a subunit of the β-cell ATP-sensitive K-channel: no association with NIDDM in while Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia 1996; 39: 1233-1236.
224. Inoue H, Ferrer J, Warren-Perry M, Zhang Y, Millns H, Turner RC et al. Sequence variants in the pancreatic islet β-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes 1997; 46: 502-507.
225. Ohtoshi K, Yamasaki Y, Gorogawa S, Hayaishi-Okano R, Node K, Matsuhisa M et al. Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance. Diabetologia 2002; 45: 1594-1601.
226. Monti LD, Barlassina C, Citterio L, Galluccio E, Berzuini C, Setola E et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 2003; 52: 1270-1275.
227. Baier LJ, Wiedrich C, Hanson RL, Bogardus C. Variant in the regulatory subunit of phosphatidylinositol 3-kinase (p85α): preliminary evidence indicates a potential role of this variant in the acute insulin response and type 2 diabetes in Pima women. Diabetes 1998; 47: 973-975.
228. Kawanishi M, Tamori Y, Masugi J, Mori H, Ito C, Hansen T et al. Prevalence of a polymorphism of the phosphatidylinositol 3-kinase p85α regulatory subunit (codon 326 Met→Ile) in Japanese NIDDM patients. Diabetes Care 1997; 20: 1043.
229. Hegele RA, Connelly PW, Scherer SW, Hanley AJ, Harris SB, Tsui LC et al. Paraoxonase-2gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 3373-3377.
230. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
231. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H et al. The Pro12Ala polymorphism in PPARγ2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 2000; 271: 212-216.
232. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J et al. A generic polymorphism of the peroxisome proliferator-activated receptor γ gene influences plasma leptin levels in obese humans. Hum Mol Genet 1998; 7: 435-440.
233. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G et al. Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes. Diabetes 1999; 48: 1466-1468.
234. Ringel J, Engeli S, Distler A, Sharma AM. Pro12Ala missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus. Biochem Biophys Res Commun 1999; 254: 450-453.
235. Clement K, Hercberg S, Passinge B, Galan P, Varroud-Vial M, Shuldiner AR et al. The Pro115Gln and Pro12Ala PPAR γ gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord 2000; 24: 391-393.
236. Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K et al. Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 2001; 44: 2220-2226.
237. Hara K, Tobe K, Okada T, Kadowaki H, Akanuma Y, Ito C et al. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes. Diabetologia 2002; 45: 740-743.
238. Lacquemant C, Chikri M, Boutin P, Samson C, Froguel P. No association between the G482S polymorphism of the proliferator-activated receptor-γ coactivator-1 (PGC-1) gene and Type II diabetes in French Caucasias. Diabetologia 2002; 45: 602-604.
239. Muller YL, Bogardus C, Pedersen O, Baier L. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor-γ coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 2003; 52: 895-898.
240. Hansen L, Hansen T, Vestergaard H, Bjorbaek C, Echwald SM, Clausen JO et al. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatase-1 is associated with insulin resistance and hypersecretion of insulin. Hum Mol Genet 1995; 4: 1313-1320.
241. Xia J, Scherer SW, Cohen PT, Majer M, Xi T, Norman RA et al. A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes. Diabetes 1998; 47: 1519-1524.
242. Hegele RA, Harris SB, Zinman B, Wang J, Cao H, Hanley AJ et al. Variation in the AU (AT)-rich element within the 3′-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians. J Clin Endocrinol Metab 1998; 83: 3980-3983.
243. Shen GQ, Ikegami H, Kawaguchi Y, Fujisawa T, Hamada Y, Ueda H et al. Asp905Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM. Diabetes Care 1998; 21: 1086-1089.
244. Doria A, Caldwell JS, Ji L, Reynet C, Rich SS, Weremowicz S et al. Trinucleotide repeats at the rad locus. Allele distributions in NIDDM and mapping to a 3-cM region on chromosome 16q. Diabetes 1995; 44: 243-247.
245. Orho M, Carlsson M, Kanninen T, Groop LC. Polymorphism at the rad gene is not associated with NIDDM in Finns. Diabetes 1996; 45: 429-433.
246. Li SR, Alcolado JC, Stocks J, Baroni MG, Oelbaum RS, Galton DJ. Genetic polymorphisms at the human liver/islet glucose transporter (GLUT2) gene locus in Caucasian and West Indian subjects with type 2 (non-insulin-dependent) diabetes mellitus. Biochim Biophys Acta 1991; 1097: 293-298.
247. Baroni MG, Alcolado JC, Pozzilli P, Cavallo MG, Li SR, Galton DJ. Polymorphisms at the GLUT2 (β-cell/liver) glucose transporter gene and non-insulin-dependent diabetes mellitus (NIDDM): analysis in affected pedigree members. Clin Genet 1992; 41: 229-234.
248. Moller AM, Jensen NM, Pildal J, Drivsholm T, Borch-Johnsen K, Urhammer SA et al. Studies of genetic variability of the glucose transporter 2 promoter in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2001; 86: 2181-2186.
249. Janssen RC, Bogardus C, Takeda J, Knowler WC, Thompson DB. Linkage analysis of acute insulin secretion with GLUT2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT2. Diabetes 1994; 43: 558-563.
250. Tanizawa Y, Riggs AC, Chiu KC, Janssen RC, Bell DS, Go RP et al. Variability of the pancreatic islet β cell/liver (GLUT 2) glucose transporter gene in NIDDM patients. Diabetologia 1994; 37: 420-427.
251. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumour necrosis factor-α gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998; 41: 430-434.
252. Meirhaeghe A, Amouyel P, Helbecque N, Cottel D, Otabe S, Froguel P et al. An uncoupling protein 3 gene polymorphism associated witb a lower risk of developing Type II diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 2000; 43: 1424-1428.
253. Wang H, Chu WS, Lu T, Hasstedt SJ, Kern PA, Elbein SC. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol Endocrinol Metab 2004; 286: E1-7.
254. Urhammer SA, Dalgaard LT, Sorensen TI, Moller AM, Andersen T, Tybjaerg-Hansen A et al. Mutational analysis of the coding region of the uncoupling protein 2 gene in obese NIDDM patients: impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin resistance. Diabetologia 1997; 40: 1227-1230.
255. Kubota T, Mori H, Tamori Y, Okazawa H, Fukuda T, Miki M et al. Molecular screening of uncoupling protein 2 gene in patients with noninsulin-dependent diabetes mellitus or obesity. J Clin Endocrinol Metab 1998; 83: 2800-2804.
256. del Bosque-Plata L, Aguilar-Salinas CA, Tusie-Luna MT, Ramirez-Jimenez S, Rodriguez-Torres M, Auron-Gomez M et al. Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population. Mol Genet Metal 2004; 81: 122-126.
257. Hansen T, Anderson CB, Echwald SM, Urhammer S, Clausen J, Vestergaard H. Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effect on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes 1997; 46: 494-501.